Organization Profile

You just read:

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

News provided by

Resverlogix Corp.

Aug 31, 2015, 07:00 ET